Fetal goitrous hypothyroidism is rare in pregnancies of euthyroid women. It is reported to be caused by excessive maternal iodine exposure, such as from oral intake. There has however been one case that occurred after hysterosalpingography (HSG) with an oil-soluble iodinated contrast medium. Here we report our own experience of fetal goiter after preconception HSG using this contrast medium.
A 27-year-old woman was referred to our hospital at 29 weeks' gestation with polyhydramnios. Her history was negative for thyroid disease and her iodine intake was normal. She had undergone treatment for infertility and, on the 11 th day of her last menstrual cycle, she had undergone HSG with an oil-soluble iodinated contrast medium. Basal body temperature indicated that she was pregnant 5 days after the procedure.
Following detailed ultrasound examination, a large homogeneous goiter, measuring 35 × 19 mm, was identified in the anterior aspect of the fetal neck (Figure 1 ), which was also visualized with fetal magnetic resonance imaging (MRI) ( Figure S1 ). Maternal thyroid function was low, confirmed by a high level of serum thyroid-stimulating hormone (TSH) and low levels of free thyroxine (T4) and free triiodothyronine (T3). At 35 week's gestation, levels had returned to normal without medical treatment and the polyhydramnios subsided in 2 weeks. The fetal goiter decreased gradually and became normal in size 1 , measuring 27 × 16 mm on MRI at 34 weeks and on ultrasound at 37 weeks' gestation ( Figures S1 and 2 ).
Elective Cesarean section was performed at 38 weeks' gestation due to cephalopelvic disproportion. A 3010-g male infant was delivered with no breathing difficulties and Apgar scores were normal. No goiter was identified and results of the thyroid function assessment using umbilical cord blood were normal. Maternal urinary iodine concentrations (UIC) were examined every month from 31 weeks' gestation to 1 month after delivery. The ratio of urinary iodine concentration to creatinine excretions (UI/Cr) decreased progressively, from 3350 μg/gCr at 31 weeks' gestation to 851 μg/gCR at 1 month postpartum ( Figure S2 ).
Fetal hypothyroidism can result in fetal goiter. Most cases of fetal hypothyroidism are associated with maternal thyroid disease however it can also be caused by maternal iodine exposure, such as from a high intake of iodine-rich food 2 and, infrequently, from HSG using an oil-soluble iodinated contrast medium 3 . Excessive iodine exposure blocks thyroid hormone synthesis, known as the Wolff-Chaikoff effect 2 . An immature fetal thyroid, until approximately 36 weeks' gestation, cannot avoid this acute effect 2 .
There has been only one case reported in the English medical literature of fetal goiter occurring after HSG with this contrast medium 3 . In that case, fetal goiter was found at 34 weeks' gestation and the goiter, along with abnormal thyroid function, persisted until birth. In addition to the natural decrease in the size of the fetal goiter, we consider our case to be quite unique because the steady decrease in maternal UI/Cr was in accordance with that of the decreasing fetal goiter in the perinatal period.
Fetal thyroid size can be measured by ultrasound or MRI and assessed using normal reference ranges of volume, circumference and width 1 . Using the nomogram of Ozguner and Sulak 1 , we evaluated the fetal goiter in our case and confirmed its natural decrease in size in the prenatal period.
The decrease in maternal UI/Cr in our case provides strong evidence that the preconception HSG caused the fetal goiter. According to Fuse et al., overall median UIC is 219.0 μg/L and UI/Cr is 234.8 μg/gCr during pregnancy, and is 135.0 μg/L and 173.8 μg/gCr in postpartum women 4 . Compared with these values, maternal UI/Cr in our case was extremely high. Kaneshige et al. found that the median value of UI/Cr peaks at 4 weeks after HSG and remains at significantly high levels compared with pre-HSG values until 41 weeks after the procedure 5 . The UI/Cr peak after HSG might have coincided with the organogenesis period in our case, and high levels of UI/Cr must have persisted until birth.
Intra-amniotic injection by cordocentesis of thyroxine after diagnosis of congenital hypothyroidism has been reported as prenatal treatment. 
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article: 
Figure S2
Changes in urinary iodine concentration (UIC) and UIC-to-creatinine excretion ratio (UI/Cr) during pregnancy and after delivery in a women with previous hysterosalpingography with an oil-soluble iodinated contrast medium.
